Log in to save to my catalogue

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2423800396

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Publication information

Publisher

New York: Nature Publishing Group US

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The SARS-CoV-2 virus is more transmissible than previous coronaviruses and causes a more serious illness than influenza. The SARS-CoV-2 receptor binding domain (RBD) of the spike protein binds to the human angiotensin-converting enzyme 2 (ACE2) receptor as a prelude to viral entry into the cell. Using a naive llama single-domain antibody library an...

Alternative Titles

Full title

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2423800396

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2423800396

Other Identifiers

ISSN

1545-9993

E-ISSN

1545-9985

DOI

10.1038/s41594-020-0469-6

How to access this item